LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,624 Cr | ₹602 Cr | ₹666 Cr | ₹994 Cr | ₹911 Cr |
What is the latest Cash Flow from Operating Activities ratio of LAURUS LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,624 Cr |
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹666 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹911 Cr |
How is Cash Flow from Operating Activities of LAURUS LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,624 Cr | 169.84 | |
| Mar2025 | ₹602 Cr | -9.62 | |
| Mar2024 | ₹666 Cr | -33.02 | |
| Mar2023 | ₹994 Cr | 9.09 | |
| Mar2022 | ₹911 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹129,239.8 Cr | 13.7% | 11.6% | 133.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 13.7% |
11.6% |
133.3% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses